explore -WSS

explore

author：knowledge 2025-09-28 15:20:59 - browse：3

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Parkinson’s finding may lead to tests and, someday, treatments

focus

WSS

Readout Newsletter: Merck, J&J, and long Covid

Ohio still needs to do more to protect the right to abortion

Ohio still needs to do more to protect the right to abortion

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

New brain studies show LSD's effects on the brain in full color

Medical school prerequisites are outdated

focus

explore

knowledge

How one medical school became remarkably diverse

Ohio still needs to do more to protect the right to abortion

Drug repurposing or repositioning? The language matters

White House drug czar issues call for 'recovery

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

After affirmative action ruling, medical educators look to 'holistic review'

Type 2 diabetes prevention programs work at large scale: study

Wildfire smoke exposes gaps in outdoor worker protections

Ventyx halts psoriasis drug development after lackluster trial results

leisure time

AI generated plenty of interest at JPM but not a lot of trust

Type 2 diabetes prevention programs work at large scale: study

What health policies could hitch a ride on a spending bill?

Dewpoint Therapeutics lays off staff after losing partnerships

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

hotspot

focus

hotspot

focus